ALZN
Alzamend Neuro, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.31
+0.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.09x
- Price / sales
- —
- Price / cash flow
- -0.92x
Enterprise value
- Enterprise value
- -$1.3M
- EV / sales
- —
- EV / EBITDA
- 0.14x
- EV / EBIT
- 0.14x
- Market cap
- $6.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026